Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
Next
(2174)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on May 06, 2022 10:28am
Insider buying
Kane Biotech Announces Update on Private Placement May 06, 2022 08:30 ET | Source: Kane Biotech Inc.
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 08, 2022 11:09am
RE:RE:Halted
Despite the high volume dump post news, the validation flowing from the certification and subsequent tangible increased revenue flows is significant and lowers the investment risk.
(14)
•••
Farmer9
X
View Profile
View Bullboard History
Comment by
Farmer9
on Apr 07, 2022 9:16pm
RE:Halted
And not a very exciting news release.
(2174)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Apr 07, 2022 11:32am
Halted
Pending news
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Mar 14, 2022 8:52pm
RE:RE:RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements
I like this CEO, he has surrounded himself with competent people and is unafraid to shift the reigns to them. There is a definitive direction for the company in niche space, with contracts in place
...more
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Feb 28, 2022 1:22pm
RE:RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements
no problem. Kane has another patent appliction published Bibliographic data: US2022054383 (A1) 2022-02-24 | In my patents list | Previous
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Feb 24, 2022 5:52pm
RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements
Yes your right, I missed it. Happy and rieved to see it actually, a BioTech implementing a business plane with targeted segments. Just never stood out for me and I remember reading the management
...more
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Feb 12, 2022 10:39am
RE:RE:RE:Kane Biotech Announces New Collaboration Agreements
also it was plainly in this statment from 2nd Q 2021 MD&A released Aug 26th 2021 which is the same statement made on the year end 2020 MD&A released Mar 25th 2021....frankly surprised
...more
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Feb 11, 2022 1:15pm
RE:RE:Kane Biotech Announces New Collaboration Agreements
mirrirworldman take a look at this at 3:44 in...the slide from a prevoius/ old presentation plainly shows the prosthetic joints etc issue as a target. Also at the end at 7:00 gives some of the many
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Feb 10, 2022 4:48pm
RE:Kane Biotech Announces New Collaboration Agreements
Looks like an investigator initiated trial designed to flow cash to the doctor and perhaps supply a tiny bit of human evidence to Kane. Its odd that this market did not come up on the Radar of
...more
(3217)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Feb 10, 2022 8:07am
Kane Biotech Announces New Collaboration Agreements
WINNIPEG, Manitoba, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has signed collaboration agreements with Dr. James Doub, MD, Assistant Professor of Medicine, University of
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Jan 12, 2022 3:25pm
Volume is picking up...a little
Daily and weekly volume (all stock exchanges) is picking up. We are well overdue for an update regarding the following topics; 1. Animalcare (sales and production); 2. New veterinarian certification
...more
(28)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Nov 12, 2021 9:58am
Summary
https://www.rally-co.ca/post/kne-v-undervalued
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Sep 30, 2021 8:03am
STEM
Snippets related to STEM from AnimalCares Group’s recent release. 28 September 2021. Animalcare Group plc ("the Company" or "Group") (AIM: ANCR), the
...more
Prev
...
21
22
23
24
25
26
27
28
29
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income